Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...

Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular ...

Patients with structural heart disease are at risk for life-threatening ventricular tachycardias (VTs). Implantable cardioverter-defibrillators (ICDs) can terminate VT, but often at the cost of ...

Supraventricular tachycardia (SVT) is a heart rhythm disorder that originates in the heart’s upper chambers, called the atria. The primary symptom of SVT is a rapid heartbeat. There are several types ...

In patients with ischaemic cardiomyopathy, an implanted cardioverter–defibrillator, and recurrent ventricular tachycardia despite the use of antiarrhythmic drugs, catheter ablation is more effective ...

For ventricular tachycardia (VT), catheter ablation is often seen as an option of last resort, however, some are questioning whether there has been too much emphasis on antiarrhythmic medication. In ...

Medically reviewed by Rafle Fernandez, MD Key Takeaways Ventricular tachycardia is when the lower chamber of the heart beats ...

Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.

Patients with structural heart disease are at risk for life-threatening ventricular tachycardias (VTs). Implantable cardioverter-defibrillators (ICDs) can terminate VT, but often at the cost of ...